20 hours ago · Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our investors and partners for lasting impact. ... Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation. Share this page. Media Contacts Scott Lessne / Charlyn ...

9 hours ago · Contacts. Media: For Bain Capital (North America): Charlyn Lusk / Scott Lessne Stanton [email protected] / [email protected] (646) 502-3549 / (646) 502-3569 For Bain Capital (Asia-Pacific ...

TOKYO & BOSTON, February 07, 2025--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

20 hours ago · TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”, “MTPC” or “the Company”) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The investment is being led by ...

12 hours ago · U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's ...

8 hours ago · Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group Corp.’s pharmaceutical unit, adding to a dealmaking boom in Japan.. The deal values Mitsubishi Tanabe Pharma Corp. at ...

12 hours ago · Following rumblings of a private equity bidding war late last year, Bain Capital has emerged triumphant on its quest to obtain Japanese drugmaker Mitsubishi Tanabe Pharma. Bain is laying out 510 ...

12 hours ago · Mitsubishi Chemical Group has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key chemical businesses. The Japanese chemical company ...

20 hours ago · TOKYO (Reuters) - Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3. ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s4188-4.18% decrease; red down pointing triangle pharmaceutical business for more than $3 billion, a deal that would allow the ...